Manfred Wuhrer Selected Research

ceramide glycanase

7/2010

Glycan profiling of urine, amniotic fluid and ascitic fluid from galactosialidosis patients reveals novel oligosaccharides with reducing end hexose and aldohexonic acid residues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manfred Wuhrer Research Topics

Disease

43	Neoplasms (Cancer) 03/2022 - 01/2011
22	Rheumatoid Arthritis 02/2022 - 11/2007
17	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2011
16	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 09/2012
10	Inflammation (Inflammations) 01/2021 - 09/2012
9	Infections 01/2022 - 08/2002
5	COVID-19 07/2022 - 01/2021
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2015
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 04/2011
5	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2011
4	Adenocarcinoma 11/2022 - 11/2017
4	Thrombocytopenia (Thrombopenia) 01/2022 - 02/2009
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2021 - 01/2011
3	Neonatal Alloimmune Thrombocytopenia 01/2022 - 01/2014
3	Virus Diseases (Viral Diseases) 12/2021 - 01/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 11/2017
3	Type 2 Diabetes Mellitus (MODY) 10/2021 - 12/2018
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 10/2013
3	Congenital Disorders of Glycosylation 10/2020 - 04/2014
3	Immune System Diseases (Immune Disorders) 10/2020 - 01/2020
3	Arthritis (Polyarthritis) 10/2019 - 01/2015
3	Urinary Tract Infections (Urinary Tract Infection) 01/2012 - 01/2005
2	Disease Progression 11/2022 - 03/2014
2	Malaria 07/2022 - 10/2021
2	Membranous Glomerulonephritis (Membranous Nephropathy) 04/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 03/2022 - 08/2016
2	Pathologic Processes 01/2022 - 01/2019
2	Thrombosis (Thrombus) 10/2021 - 01/2021
2	Melanoma (Melanoma, Malignant) 05/2021 - 01/2018
2	Myasthenia Gravis 01/2021 - 01/2011
2	Critical Illness (Critically Ill) 01/2021 - 01/2021
2	Multiple Myeloma 12/2020 - 01/2019
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020 - 01/2018
2	Communicable Diseases (Infectious Diseases) 01/2020 - 12/2014
2	Leukemia 01/2019 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 01/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 01/2018
2	Peritonitis 01/2018 - 01/2016
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2017 - 04/2015
2	Vasculitis (Vasculitides) 03/2017 - 04/2015
2	Hemolysis 01/2017 - 09/2014
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2017 - 12/2014
2	Noncommunicable Diseases 08/2016 - 01/2016
1	Dengue (Dengue Fever) 07/2022

Drug/Important Bio-Agent (IBA)

63	Immunoglobulin G (IgG)IBA 07/2022 - 11/2007
56	Polysaccharides (Glycans)IBA 11/2022 - 11/2007
22	Proteins (Proteins, Gene)FDA Link 04/2022 - 04/2010
21	AntibodiesIBA 10/2021 - 01/2011
17	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2011
13	AntigensIBA 07/2022 - 05/2011
13	AutoantibodiesIBA 02/2022 - 01/2009
11	Blood Proteins (Serum Proteins)IBA 10/2021 - 09/2012
10	Glycoproteins (Glycoprotein)IBA 01/2021 - 01/2011
9	Biological ProductsIBA 01/2022 - 01/2015
8	Mannose (D-Mannose)IBA 03/2022 - 01/2005
7	Immunoglobulins (Immunoglobulin)IBA 04/2022 - 03/2014
7	GlycosphingolipidsIBA 01/2022 - 07/2010
7	Anti-Citrullinated Protein AntibodiesIBA 01/2022 - 06/2010
7	Immunoglobulin A (IgA)IBA 10/2021 - 09/2012
6	Galactose (Galactopyranose)FDA LinkGeneric 12/2020 - 01/2015
5	Monoclonal AntibodiesIBA 01/2022 - 08/2002
4	GlycoconjugatesIBA 01/2022 - 04/2010
4	VaccinesIBA 01/2022 - 01/2020
4	LectinsIBA 01/2021 - 01/2011
4	CytokinesIBA 01/2021 - 12/2014
4	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2020 - 01/2018
4	C-Reactive ProteinIBA 01/2018 - 12/2014
3	LipidsIBA 01/2022 - 04/2014
3	EpitopesIBA 01/2022 - 09/2012
3	IsoantibodiesIBA 01/2022 - 02/2009
3	LigandsIBA 01/2020 - 01/2019
3	Immunoglobulin M (IgM)IBA 01/2019 - 01/2011
3	Carrier Proteins (Binding Protein)IBA 01/2019 - 01/2015
3	OligosaccharidesIBA 01/2018 - 07/2010
3	GlycopeptidesIBA 01/2018 - 04/2010
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017 - 01/2011
2	Antigen-Antibody Complex (Immune Complex)IBA 04/2022 - 10/2021
2	Sialic AcidsIBA 03/2022 - 01/2018
2	CarbohydratesIBA 01/2022 - 01/2018
2	acetyl 4-aminosalicylic acidIBA 01/2022 - 10/2019
2	Formaldehyde (Formol)FDA Link 01/2022 - 10/2015
2	Inosine Triphosphate (ITP)IBA 12/2021 - 01/2020
2	SialyltransferasesIBA 11/2021 - 01/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2016
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2011
2	MucinsIBA 12/2020 - 10/2014
2	EnzymesIBA 11/2020 - 01/2018
2	C-Type Lectins (C-Type Lectin)IBA 08/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2016
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2017 - 04/2015
2	Myeloblastin (Proteinase 3)IBA 03/2017 - 04/2015
2	Human Platelet AntigensIBA 01/2014 - 02/2009
2	Tumor Biomarkers (Tumor Markers)IBA 10/2013 - 09/2012
2	Galectin 1 (LGALS1)IBA 09/2012 - 01/2011
2	AnionsIBA 06/2012 - 07/2010
2	GlycolipidsIBA 02/2004 - 08/2002

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2011
5	Lasers (Laser) 01/2022 - 11/2013
2	Aftercare (After-Treatment) 05/2021 - 03/2014